Medical illustration of the eye emphasizing ocular health

Newsroom

Press releases

JULY 1, 2026
Nicox’s NCX 470 New Drug Application Submitted in the United States by Kowa, with Associated €3 million Milestone Payment
Read More
FEBRUARY 10, 2026
Nicox to Present Data from NCX 470 Phase 3 Studies at American Glaucoma Society (AGS) Annual Meeting 2026
Read More
AUGUST 21, 2025
Nicox Announces Positive Results from the NCX 470 Phase 3 Denali Trial in Glaucoma Patients
Read More

Publications

NCX 470 Phase 3 Efficacy and Safety — Poster Presentation
Read More
Mechanisms of Optic Nerve Protection in Glaucoma — Review Article
Read More
Comparative Efficacy of Novel IOP-Lowering Agents in Open-Angle Glaucoma
Read More

Explore Our Products and Pipeline